| Predicate |
Object |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-606
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2250-0067
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2300-416
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-91558
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2002-91541 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-915
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2-91
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L31-16 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L31-16 |
| filingDate |
2004-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_72b1aad1a3281c2816a87dbf814dac17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d177293f81f8b03ba8ca05c76d5f6eb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bcd270e1dc46cf855bd2311bb2301dfa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1096400dc0b5c624dcef6b838427c60c |
| publicationDate |
2005-04-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2005085902-A1 |
| titleOfInvention |
Local delivery of rapamycin for treatment of proliferative sequelae associated with PTCA procedures,Including delivery using a modified stent |
| abstract |
Methods of preparing intravascular stents with a polymeric coating containing macrocyclic lactone (such as rapamycin or its analogs), stents and stent graphs with such coatings, and methods of treating a coronary artery with such devices. The macrocyclic lactone-based polymeric coating facilitates the performance of such devices in inhibiting restenosis. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8038708-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8769794-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007162103-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8486960-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010305682-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009012605-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007112421-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9452156-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007032865-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2006257450-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2009011005-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2007027535-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10182928-B2 |
| priorityDate |
1997-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |